2014 Physician Quality Reporting System (PQRS)

Quality-Data Code (QDC) Categories

12/13/2013
CPT only copyright 2013 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Apply to Government Use. Fee schedules,
relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice
medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
 2014 Physician Quality Reporting System (PQRS) Quality-Data Code (QDC) Categories
Select a quality-data code (QDC) choice corresponding to the quality action performed by the TIN/NPI as noted in the measure specifications. An “&” sign between QDCs notes that more than one QDC is required. The QDCs that vary by reporting
mechanism are listed separately for each measure in which this applies. For reporting options available for each measure, refer to the 2014 Physician Quality Reporting System (PQRS) Measures List. TIN/NPIs who only report QDCs listed in the
“Performance Not Met” category for a measure will result in a performance rate of 0%. Measures with a 0% performance rate will not count towards the criteria for satisfactory reporting. The 2014 Physician Quality Reporting System (PQRS) Measure
Specifications Manual for Claims and Registry Reporting of Individual Measures and the 2014 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual should be referenced for full understanding of the measures.

PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
3046F
3046F-8P
Diabetes: Hemoglobin A1c Poor 3044F
1 0059 (NOTE: A lower performance N/A N/A N/A No Report
Control 3045F
rate is desirable for this
measure)
3049F
Diabetes: Low Density Lipoprotein
2 0064 3048F N/A N/A N/A No Report 3050F
(LDL-C) Control (<100 mg/dL)
3048F-8P
Individual Measures Reporting:
Heart Failure(HF): Angiotensin-
Converting Enzyme (ACE) Inhibitor or
5 0081 4010F 4010F-1P 4010F-2P 4010F-3P No Report 4010F-8P
Angiotensin Receptor Blocker (ARB)
Therapy for Left Ventricular Systolic
Dysfunction (LVSD)
Measures Group Reporting: Heart
Failure(HF): Angiotensin-Converting
3022F
Enzyme (ACE) Inhibitor or Angiotensin
5 0081 4010F & 3021F 4010F-1P & 3021F 4010F-2P & 3021F 4010F-3P & 3021F 3021F-8P 4010F-8P & 3021F
Receptor Blocker (ARB) Therapy for
No Report
Left Ventricular Systolic Dysfunction
(LVSD)
Coronary Artery Disease (CAD):
6 0067 4086F 4086F-1P 4086F-2P 4086F-3P No Report 4086F-8P
Antiplatelet Therapy
Coronary Artery Disease (CAD): Beta-
G9189 G9190 G9191 G9192 No Report G9188
Blocker Therapy- Prior Myocardial
7 0070 ------------ ------------ ------------ ------------ ------------ ------------
Infarction (MI) or Left Ventricular
4008F 4008F-1P 4008F-2P 4008F-3P No Report 4008F-8P
Systolic Dysfunction (LVEF < 40%)
Individual Measures Reporting:
Heart Failure(HF): Beta-Blocker G8451
8 0083 G8450 N/A N/A N/A G8452
Therapy for Left Ventricular Systolic No Report
Dysfunction (LVSD)

Version 5.0 12/13/13 Page 2 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Measures Group Reporting: Heart G8541
Failure(HF): Beta-Blocker Therapy for G8395 G8452
8 0083 G8450 & G8923 N/A N/A N/A
Left Ventricular Systolic Dysfunction G8396 G8923
(LVSD) No Report
G8128
G8126 N/A N/A N/A No Report G8127
Anti-depressant Medication
9 0105 ------------ ------------ ------------ ------------ ------------ ------------
Management
G9194 N/A N/A N/A G9193 G9195
No Report
Primary Open-Angle Glaucoma
12 0086 2027F 2027F-1P N/A N/A No Report 2027F-8P
(POAG): Optic Nerve Evaluation
Age-Related Macular Degeneration
14 0087 2019F 2019F-1P 2019F-2P N/A No Report 2019F-8P
(AMD): Dilated Macular Examination
Diabetic Retinopathy: Documentation
of Presence or Absence of Macular
18 0088 2021F 2021F-1P 2021F-2P N/A No Report 2021F-8P
Edema and Level of Severity of
Retinopathy
Diabetic Retinopathy: Communication
G8398
19 0089 with the Physician Managing Ongoing 5010F & G8397 5010F-1P & G8397 5010F-2P & G8397 N/A 5010F-8P & G8397
No Report
Diabetes Care
Perioperative Care: Timing of
G8629 G8631
20 0270 Prophylactic Parenteral Antibiotic – N/A N/A N/A G8632
G8630 No Report
Ordering Physician
Perioperative Care: Selection of
21 0268 Prophylactic Antibiotic – First OR G9197 G9196 N/A N/A No Report G9198
Second Generation Cephalosporin
Perioperative Care: Discontinuation of
4042F
22 0271 Prophylactic Parenteral Antibiotics 4049F & 4046F 4049F-1P & 4046F N/A N/A 4049F-8P & 4046F
No Report
(Non-Cardiac Procedures)
Perioperative Care: Venous
23 0239 Thromboembolism (VTE) Prophylaxis 4044F 4044F-1P N/A N/A No Report 4044F-8P
(When Indicated in ALL Patients)
Osteoporosis: Communication with the
Physician Managing On-going Care
24 0045 Post-Fracture of Hip, Spine or Distal 5015F 5015F-1P 5015F-2P N/A No Report 5015F-8P
Radius for Men and Women Aged 50
Years and Older
Aspirin at Arrival for Acute Myocardial
28 0092 4084F 4084F-1P 4084F-2P N/A No Report 4084F-8P
Infarction (AMI)
Version 5.0 12/13/13 Page 3 of 23
CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Perioperative Care: Timing of
4047F-8P
30 0269 Prophylactic Antibiotic – Administering 4048F 4048F-1P N/A N/A 4048F-8P
No Report
Physician
Stroke and Stroke Rehabilitation:
Venous Thromboembolism (VTE) G9199
31 0420 G9201 N/A N/A N/A G9200
Prophylaxis for Ischemic Stroke or No Report
Intracranial Hemorrhage
Stroke and Stroke Rehabilitation: G8697
32 0325 G8696 N/A N/A N/A G8698
Discharged on Antithrombotic Therapy No Report
Stroke and Stroke Rehabilitation:
33 0241 Anticoagulant Therapy Prescribed for 4075F 4075F-1P 4075F-2P N/A No Report 4075F-8P
Atrial Fibrillation (AF) at Discharge
Stroke and Stroke Rehabilitation: 6020F
35 0243 6010F & 6015F 6010F-1P & 6015F 6010F-2P & 6015F N/A 6010F-8P & 6015F
Screening for Dysphagia No Report
Stroke and Stroke Rehabilitation: G8700
36 0244 G8699 N/A N/A N/A G8701
Rehabilitation Services Ordered No Report
Screening or Therapy for Osteoporosis G8401
39 0046 G8399 N/A N/A N/A G8400
for Women Aged 65 Years and Older No Report
Osteoporosis: Management Following
3096F 3096F-1P 3096F-2P 3096F-3P 3096F-8P
Fracture of Hip, Spine or Distal Radius G8634
40 0045 3095F 3095F-1P 3095F-2P 3095F-3P 3095F-8P
for Men and Women Aged 50 Years No Report
G8633 G8635
and Older
Osteoporosis: Pharmacologic Therapy
41 0049 for Men and Women Aged 50 Years 4005F 4005F-1P 4005F-2P 4005F-3P No Report 4005F-8P
and Older
Coronary Artery Bypass Graft (CABG):
Use of Internal Mammary Artery (IMA)
43 0516 4110F 4110F-1P N/A N/A No Report 4110F-8P
in Patients with Isolated CABG
Surgery
Coronary Artery Bypass Graft (CABG):
44 0235 Preoperative Beta-Blocker in Patients 4115F 4115F-1P N/A N/A No Report 4115F-8P
with Isolated CABG Surgery
Perioperative Care: Discontinuation of
G8703
45 0637 Prophylactic Parenteral Antibiotics 4043F & G8702 4043F-1P & G8702 N/A N/A 4043F-8P & G8702
No Report
(Cardiac Procedures)
46 0097 Medication Reconciliation 1111F N/A N/A N/A No Report 1111F-8P

Version 5.0 12/13/13 Page 4 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
1123F
47 0326 Advance Care Plan N/A N/A N/A No Report 1123F-8P
1124F
Urinary Incontinence: Assessment of
Presence or Absence of Urinary
48 0098 1090F 1090F-1P N/A N/A No Report 1090F-8P
Incontinence in Women Aged 65
Years and Older
Urinary Incontinence: Characterization
49 0099 of Urinary Incontinence in Women 1091F N/A N/A N/A No Report 1091F-8P
Aged 65 Years and Older
Urinary Incontinence: Plan of Care for
50 0100 Urinary Incontinence in Women Aged 0509F N/A N/A N/A No Report 0509F-8P
65 Years and Older
Chronic Obstructive Pulmonary
51 0091 Disease (COPD): Spirometry 3023F 3023F-1P 3023F-2P 3023F-3P No Report 3023F-8P
Evaluation
Chronic Obstructive Pulmonary G8925
52 0102 Disease (COPD): Inhaled 4025F & G8924 4025F-1P & G8924 4025F-2P & G8924 4025F-3P & G8924 G8926 4025F-8P & G8924
Bronchodilator Therapy No Report
Individual Measures Reporting:
Asthma: Pharmacologic Therapy for 4140F
53 0047 N/A 4140F-2P N/A No Report 4140F-8P
Persistent Asthma – Ambulatory Care 4144F
Setting
Measures Group Reporting: Asthma:
1039F
53 0047 Pharmacologic Therapy for Persistent 4140F & 1038F N/A 4140F & 1038F N/A 4140F-8P & 1038F
No Report
Asthma – Ambulatory Care Setting
Emergency Medicine: 12-Lead
54 0090 Electrocardiogram (ECG) Performed 3120F 3120F-1P 3120F-2P N/A No Report 3120F-8P
for Non-Traumatic Chest Pain
Emergency Medicine: 12-Lead
55 0093 Electrocardiogram (ECG) Performed G8704 G8705 G8706 N/A No Report G8707
for Syncope
Emergency Medicine: Community-
56 0232 Acquired Bacterial Pneumonia (CAP): 2010F N/A N/A N/A No Report 2010F-8P
Vital Signs
Emergency Medicine: Community-
59 0096 Acquired Bacterial Pneumonia (CAP): 4045F 4045F-1P 4045F-2P 4045F-3P No Report 4045F-8P
Empiric Antibiotic
Asthma: Assessment of Asthma 2015F-8P
64 0001 2015F & 2016F N/A N/A N/A No Report
Control – Ambulatory Care Setting 2016F-8P
Version 5.0 12/13/13 Page 5 of 23
CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Appropriate Treatment for Children
65 0069 G8708 G8709 N/A N/A No Report G8710
with Upper Respiratory Infection (URI)
Appropriate Testing for Children with
66 0002 3210F N/A N/A N/A 3210F-8P
Pharyngitis No Report
Hematology: Myelodysplastic
Syndrome (MDS) and Acute
67 0377 3155F 3155F-1P 3155F-2P 3155F-3P No Report 3155F-8P
Leukemias: Baseline Cytogenetic
Testing Performed on Bone Marrow
Hematology: Myelodysplastic
Syndrome (MDS): Documentation of 4095F
68 0378 3160F & 4090F N/A N/A 3160F-3P & 4090F 3160F-8P & 4090F
Iron Stores in Patients Receiving No Report
Erythropoietin Therapy
Hematology: Multiple Myeloma:
69 0380 4100F 4100F-1P 4100F-2P N/A No Report 4100F-8P
Treatment with Bisphosphonates
Hematology: Chronic Lymphocytic
70 0379 Leukemia (CLL): Baseline Flow 3170F 3170F-1P 3170F-2P 3170F-3P No Report 3170F-8P
Cytometry
3316F
3370F
Breast Cancer: Hormonal Therapy for
4179F & 3374F & 3315F 4179F-1P & 3374F & 3315F 4179F-2P & 3374F & 3315F 4179F-3P & 3374F & 3315F 3372F 4179F-8P & 3374F & 3315F
Stage IC - IIIC Estrogen
71 0387 4179F & 3376F & 3315F 4179F-1P & 3376F & 3315F 4179F-2P & 3376F & 3315F 4179F-3P & 3376F & 3315F 3380F 4179F-8P & 3376F & 3315F
Receptor/Progesterone Receptor
4179F & 3378F & 3315F 4179F-1P & 3378F & 3315F 4179F-2P & 3378F & 3315F 4179F-3P & 3378F & 3315F 3316F-8P 4179F-8P & 3378F & 3315F
(ER/PR) Positive Breast Cancer
3370F-8P
No Report
G8928 & 3388F
3382F
3384F
Colon Cancer: Chemotherapy for G8929 & 3388F
72 0385 G8927 & 3388F N/A N/A N/A 3386F
AJCC Stage III Colon Cancer Patients
3390F
3382F-8P
No Report
Prevention of Catheter-Related
Bloodstream Infections (CRBSI):
76 0464 6030F 6030F-1P N/A N/A No Report 6030F-8P
Central Venous Catheter (CVC)
Insertion Protocol
Adult Kidney Disease: Hemodialysis
81 0323 G8713 N/A N/A N/A No Report G8717
Adequacy: Solute
Adult Kidney Disease: Peritoneal
82 0321 G8718 N/A N/A N/A No Report G8720
Dialysis Adequacy: Solute

Version 5.0 12/13/13 Page 6 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Hepatitis C: Confirmation of Hepatitis
83 0393 3265F 3265F-1P 3265F-2P N/A No Report 3265F-8P
C Viremia
Measures Group Reporting:
4151F
84 0395 Hepatitis C: Ribonucleic Acid (RNA) G9203 & G9205 N/A N/A N/A G9204 & G9205
No Report
Testing Before Initiating Treatment
84 0395 Individual Measures Reporting:
Hepatitis C: Ribonucleic Acid (RNA) G9203 N/A N/A N/A No Report G9204
Testing Before Initiating Treatment
Measures Group Reporting:
G8458
85 0396 Hepatitis C: HCV Genotype Testing G9207 & G9206 N/A N/A N/A G9208 & G9206
No Report
Prior to Treatment
Individual Measures Reporting:
85 0396 Hepatitis C: HCV Genotype Testing G9207 N/A N/A N/A No Report G9208
Prior to Treatment
Measures Group Reporting:
Hepatitis C: Hepatitis C Virus (HCV) G9210 & G8461
87 0398 Ribonucleic Acid (RNA) Testing G9209 & G8461 N/A N/A N/A G8460 G9211 & G8461
Between 4-12 Weeks After Initiation of No Report
Treatment
Individual Measures Reporting:
Hepatitis C: Hepatitis C Virus (HCV)
G9210
87 0398 Ribonucleic Acid (RNA) Testing G9209 N/A N/A N/A G9211
No Report
Between 4-12 Weeks After Initiation of
Treatment
Acute Otitis Externa (AOE): Topical
91 0653 4130F 4130F-1P 4130F-2P N/A No Report 4130F-8P
Therapy
Acute Otitis Externa (AOE): Systemic
93 0654 Antimicrobial Therapy – Avoidance of 4132F 4131F-1P N/A N/A No Report 4131F
Inappropriate Use
Breast Cancer Resection Pathology
Reporting: pT Category (Primary 3250F
99 0391 3260F 3260F-1P N/A N/A 3260F-8P
Tumor) and pN Category (Regional No Report
Lymph Nodes) with Histologic Grade
Colorectal Cancer Resection
Pathology Reporting: pT Category G8722
100 0392 (Primary Tumor) and pN Category G8721 N/A N/A N/A G8723 G8724
(Regional Lymph Nodes) with No Report
Histologic Grade

Version 5.0 12/13/13 Page 7 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
3272F
Prostate Cancer: Avoidance of
3273F
102 0389 Overuse of Bone Scan for Staging Low 3270F & 3271F 3269F-1P & 3271F N/A 3269F-3P & 3271F 3269F & 3271F
3274F
Risk Prostate Cancer Patients
No Report
Prostate Cancer: Adjuvant Hormonal
G8464
104 0390 Therapy for High Risk Prostate Cancer 4164F & G8465 4164F-1P & G8465 4164F-2P & G8465 N/A 4164F-8P & G8465
No Report
Patients
Adult Major Depressive Disorder 1040F-8P
106 0103 (MDD): Comprehensive Diagnostic 1040F & G8930 N/A N/A N/A No Report G8931
Evaluation: Diagnosis and Severity
Adult Major Depressive Disorder
107 0104 G8932 N/A N/A N/A G8933
(MDD): Suicide Risk Assessment No Report
Rheumatoid Arthritis (RA): Disease
108 0054 Modifying Anti-Rheumatic Drug 4187F 4187F-1P N/A N/A No Report 4187F-8P
(DMARD) Therapy
Osteoarthritis (OA): Function and Pain
109 0050 1006F N/A N/A N/A No Report 1006F-8P
Assessment
G8483
Preventive Care and Screening:
110 0041 G8482 N/A N/A N/A G0919 G8484
Influenza Immunization
No Report
Pneumonia Vaccination Status for
111 0043 4040F N/A N/A N/A No Report 4040F-8P
Older Adults
Preventive Care and Screening:
112 3014F 3014F-1P N/A N/A No Report 3014F-8P
Breast Cancer Screening
113 0034 Colorectal Cancer Screening 3017F 3017F-1P N/A N/A No Report 3017F-8P
Avoidance of Antibiotic Treatment in
116 0058 4124F 4120F-1P N/A N/A No Report 4120F
Adults With Acute Bronchitis
2022F
2022F-8P
2024F
117 0055 Diabetes: Eye Exam N/A N/A N/A No Report 2024F-8P
2026F
2026F-8P
3072F
Coronary Artery Disease (CAD):
G8936
Angiotensin-Converting Enzyme (ACE)
G8935 No Report G8937
Inhibitor or Angiotensin Receptor
118 0066 ------------ N/A N/A N/A ------------ ------------
Blocker (ARB) Therapy - Diabetes or
G8473 G8474 G8475
Left Ventricular Systolic Dysfunction
No Report
(LVEF < 40%)

Version 5.0 12/13/13 Page 8 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
3060F
3061F 3060F-8P
Diabetes: Medical Attention for
119 0062 3062F N/A N/A N/A No Report 3061F-8P
Nephropathy
3066F 3062F-8P
G8506
Adult Kidney Disease: G8726
121 1668 G8725 N/A N/A N/A G8728
LaboratoryTesting (Lipid Profile) No Report
Adult Kidney Disease: Blood Pressure G8476 G8478
122 AQA N/A N/A N/A No Report
Management G8477 & 0513F 0513F-8P & G8477

Adult Kidney Disease: Patients On G0908 & 4171F G0909 & 4171F
123 1666 Erythropoiesis-Stimulating Agent (NOTE: A lower performance N/A N/A N/A 4172F G0910 & 4171F
(ESA) - Hemoglobin Level > 12.0 g/dL rate is desirable for this No Report
measure)
Diabetes Mellitus: Diabetic Foot and
G8406
126 0417 Ankle Care, Peripheral Neuropathy – G8404 N/A N/A N/A G8405
No Report
Neurological Evaluation
Diabetes Mellitus: Diabetic Foot and
G8416
127 0416 Ankle Care, Ulcer Prevention – G8410 N/A N/A N/A G8415
No Report
Evaluation of Footwear
Preventive Care and Screening: Body G8420 G8422
G8421
128 0421 Mass Index (BMI) Screening and G8417 N/A N/A N/A G8938
G8419
Follow-Up G8418 No Report
Documentation of Current Medications G8430
130 0419 G8427 N/A N/A N/A G8428
in the Medical Record No Report
G8442
G8730 G8732
131 0420 Pain Assessment and Follow-Up N/A N/A N/A G8939
G8731 G8509
No Report
Preventive Care and Screening: G8433
G8431 G8432
134 0418 Screening for Clinical Depression and N/A N/A N/A G8940
G8510 G8511
Follow-Up Plan No Report
Melanoma: Continuity of Care – Recall
137 0650 7010F N/A N/A 7010F-3P No Report 7010F-8P
System
138 N/A Melanoma: Coordination of Care 5050F N/A 5050F-2P 5050F-3P No Report 5050F-8P
Age-Related Macular Degeneration
140 0566 (AMD): Counseling on Antioxidant 4177F N/A N/A N/A No Report 4177F-8P
Supplement

Version 5.0 12/13/13 Page 9 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Primary Open-Angle Glaucoma
(POAG): Reduction of Intraocular 3284F 0517F-8P & 3285F
141 0563 N/A N/A N/A No Report
Pressure (IOP) by 15% OR 0517F & 3285F 3284F-8P
Documentation of a Plan of Care
Osteoarthritis (OA): Assessment for
142 0051 Use of Anti-Inflammatory or Analgesic 1007F N/A N/A N/A No Report 1007F-8P
Over-the-Counter (OTC) Medications
Oncology: Medical and Radiation – 1125F
143 0384 N/A N/A N/A No Report 1125F-8P
Pain Intensity Quantified 1126F
Oncology: Medical and Radiation –
144 0383 0521F N/A N/A N/A No Report 0521F-8P
Plan of Care for Pain
Radiology: Exposure Time Reported
145 0510 6045F N/A N/A N/A No Report 6045F-8P
for Procedures Using Fluoroscopy
3340F
3343F 3341F
Radiology: Inappropriate Use of
(NOTE: A lower performance 3342F
146 0508 “Probably Benign” Assessment N/A N/A N/A No Report
rate is desirable for this 3344F
Category in Mammography Screening
measure) 3345F
3350F
Nuclear Medicine: Correlation with
Existing Imaging Studies for All
147 N/A 3570F N/A N/A 3570F-3P No Report 3570F-8P
Patients Undergoing Bone
Scintigraphy
148 0322 Back Pain: Initial Visit 1130F N/A N/A N/A No Report 1130F-8P
149 0319 Back Pain: Physical Exam 2040F N/A N/A N/A No Report 2040F–8P
150 0315 Back Pain: Advice for Normal Activities 4245F N/A N/A N/A No Report 4245F-8P
151 0313 Back Pain: Advice Against Bed Rest 4248F N/A N/A N/A No Report 4248F-8P
1101F
154 0101 Falls: Risk Assessment 3288F & 1100F 3288F-1P & 1100F N/A N/A 1101F-8P 3288F-8P & 1100F
No Report
155 0101 Falls: Plan of Care 0518F 0518F-1P N/A N/A No Report 0518F-8P
Oncology: Radiation Dose Limits to
156 0382 0520F N/A N/A N/A No Report 0520F-8P
Normal Tissues
Thoracic Surgery: Recording of
157 0455 Clinical Stage Prior to Lung Cancer or 3323F N/A N/A N/A No Report 3323F-8P
Esophageal Cancer Resection
HIV/AIDS: CD4+ Cell Count or CD4+
159 0404 G9214 N/A N/A N/A No Report G9215
Percentage Performed

Version 5.0 12/13/13 Page 10 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
G9222 G9219 N/A N/A No Report G9217
Individual Measures Reporting: ------------ ------------ ------------ ------------ ------------ ------------
160 0405 HIV/AIDS: Pneumocystis Jiroveci G9223 G9220 N/A N/A No Report G9218
Pneumonia (PCP) Prophylaxis ------------ ------------ ------------ ------------ ------------ ------------
G9221 N/A N/A N/A No Report G9216
Measures Group Reporting: 3495F
G9217 & 3494F
160 0405 HIV/AIDS: Pneumocystis Jiroveci G9222 & 3494F G9219 & 3494F N/A N/A 3496F
3494F-8P
Pneumonia (PCP) Prophylaxis No Report
163 0056 Diabetes: Foot Exam G9226 G9224 N/A N/A No Report G9225
G8569
Coronary Artery Bypass Graft (CABG): (NOTE: A lower performance
164 0129 N/A N/A N/A No Report G8570
Prolonged Intubation rate is desirable for this
measure)
G8571
Coronary Artery Bypass Graft (CABG): (NOTE: A lower performance
165 0130 N/A N/A N/A No Report G8572
Deep Sternal Wound Infection Rate rate is desirable for this
measure)
G8573
Coronary Artery Bypass Graft (CABG): (NOTE: A lower performance
166 0131 N.A N/A N/A No Report G8574
Stroke rate is desirable for this
measure)
G8575
Coronary Artery Bypass Graft (CABG): (NOTE: A lower performance
167 0114 N/A N/A N/A No Report G8576
Postoperative Renal Failure rate is desirable for this
measure)
G8577
Coronary Artery Bypass Graft (CABG): (NOTE: A lower performance
168 0115 N/A N/A N/A No Report G8578
Surgical Re-exploration rate is desirable for this
measure)
Coronary Artery Bypass Graft (CABG): G8580
169 0237 G8579 N/A N/A N/A G8581
Antiplatelet Medications at Discharge No Report
Coronary Artery Bypass Graft (CABG):
G8583
170 0238 Beta-Blockers Administered at G8582 N/A N/A N/A G8584
No Report
Discharge
Coronary Artery Bypass Graft (CABG): G8586
171 0118 G8585 N/A N/A N/A G8587
Anti-Lipid Treatment at Discharge No Report

Version 5.0 12/13/13 Page 11 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Hemodialysis Vascular Access
Decision-Making by Surgeon to G8531
172 0259 G8530 N/A N/A N/A G8532
Maximize Placement of Autogenous No Report
Arterial Venous (AV) Fistula
Preventive Care and Screening:
173 AQA 3016F 3016F-1P N/A N/A No Report 3016F-8P
Unhealthy Alcohol Use – Screening
Rheumatoid Arthritis (RA): 4196F
176 AQA 3455F & 4195F 3455F-1P & 4195F N/A N/A 3455F-8P & 4195F
Tuberculosis Screening No Report
3470F
Rheumatoid Arthritis (RA): Periodic
177 AQA 3471F N/A N/A N/A No Report 3470F-8P
Assessment of Disease Activity
3472F
Rheumatoid Arthritis (RA): Functional
178 AQA 1170F N/A N/A N/A No Report 1170F-8P
Status Assessment
Rheumatoid Arthritis (RA):
3475F
179 AQA Assessment and Classification of N/A N/A N/A No Report 3475F-8P
3476F
Disease Prognosis
4192F
Rheumatoid Arthritis (RA): 4194F-8P
180 AQA 4193F 0540F-1P & 4194F N/A N/A No Report
Glucocorticoid Management 0540F-8P & 4194F
4194F & 0540F
G8535
Elder Maltreatment Screen and G8733 G8536
181 AQA N/A N/A N/A G8941
Follow-Up Plan G8734 G8735
No Report
G8539
G8540 G8541
182 AQA Functional Outcome Assessment G8542 N/A N/A N/A
G9227No Report G8543
G8942
Hepatitis C: Hepatitis A Vaccination in 4148F
183 0399 4148F-1P 4148F-2P N/A No Report 4148F-8P
Patients with Hepatitis C Virus (HCV) 3215F
Endoscopy/Polyp Surveillance:
Colonoscopy Interval for Patients with
185 0659 0529F 0529F-1P N/A 0529F-3P No Report 0529F-8P
a History of Adenomatous Polyps –
Avoidance of Inappropriate Use

Stroke and Stroke Rehabilitation: G8601

187 N/A G8600 N/A N/A N/A G8602
Thrombolytic Therapy No Report

Cataracts: 20/40 or Better Visual

191 0565 Acuity within 90 Days Following 4175F N/A N/A N/A No Report 4175F-8P
Cataract Surgery

Version 5.0 12/13/13 Page 12 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Cataracts: Complications within 30 G8627
Days Following Cataract Surgery (NOTE: A lower performance
192 0564 N/A N/A N/A No Report G8628
Requiring Additional Surgical rate is desirable for this
Procedures measure)
Perioperative Temperature 4256F
193 0454 4250F & 4255F 4250F-1P & 4255F N/A N/A 4250F-8P & 4255F
Management No Report
3300F
194 0386 Oncology: Cancer Stage Documented N/A N/A N/A No Report 3301F-8P
3301F
Radiology: Stenosis Measurement in
195 0507 3100F N/A N/A N/A No Report 3100F-8P
Carotid Imaging Studies
G8737 & 4013F-8P
Coronary Artery Disease (CAD): Lipid G8736
197 0074 G8737 & 0556F & 4013F-1P G8737 & 0556F & 4013F-2P G8737 & 0556F & 4013F-3P No Report G8737 & 0556F-8P
Control G8737 & 4013F & 0556F
G8943
Heart Failure: Left Ventricular Ejection G8738
198 0079 N/A N/A N/A No Report G8740
Fraction (LVEF) Assessment G8739
Ischemic Vascular Disease (IVD): Use
204 0068 G8598 N/A N/A N/A No Report G8599
of Aspirin or Another Antithrombotic
HIV/AIDS: Sexually Transmitted
G9229
205 0409 Disease Screening for Chlamydia, G9228 N/A N/A N/A G9230
No Report
Gonorrhea, and Syphilis
Functional Deficit: Change in Risk-
G8647 G8649
217 0422 Adjusted Functional Status for Patients N/A N/A N/A G8650
G8648 No Report
with Knee Impairments
Functional Deficit: Change in Risk-
G8651 G8653
218 0423 Adjusted Functional Status for Patients N/A N/A N/A G8654
G8652 No Report
with Hip Impairments
Functional Deficit: Change in Risk-
Adjusted Functional Status for Patients G8655 G8657
219 0424 N/A N/A N/A G8658
with Lower Leg, Foot or Ankle G8656 No Report
Impairments
Functional Deficit: Change in Risk-
G8659 G8661
220 0425 Adjusted Functional Status for Patients N/A N/A N/A G8662
G8660 No Report
with Lumbar Spine Impairments
Functional Deficit: Change in Risk-
G8663 G8665
221 0426 Adjusted Functional Status for Patients N/A N/A N/A G8666
G8664 No Report
with Shoulder Impairments
Functional Deficit: Change in Risk-
G8667 G8669
222 0427 Adjusted Functional Status for Patients N/A N/A N/A G8670
G8668 No Report
with Elbow, Wrist or Hand Impairments
Version 5.0 12/13/13 Page 13 of 23
CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Functional Deficit: Change in Risk-
Adjusted Functional Status for Patients
G8671 G8673
223 0428 with Neck, Cranium, Mandible, N/A N/A N/A G8674
G8672 No Report
Thoracic Spine, Ribs, or Other General
Orthopedic Impairments
Melanoma: Overutilization of Imaging
224 0562 3320F 3319F-1P N/A 3319F-3P No Report 3319F
Studies in Melanoma
Radiology: Reminder System for
225 0509 7025F N/A N/A N/A No Report 7025F-8P
Mammograms
Preventive Care and Screening:
4004F
226 0028 Tobacco Use: Screening and 4004F-1P N/A N/A No Report 4004F-8P
1036F
Cessation Intervention
Heart Failure (HF): Left Ventricular G8683
228 N/A G8682 N/A N/A N/A G8685
Function (LVF) Testing No Report
Asthma: Tobacco Use: Screening -
231 N/A 1031F N/A N/A N/A No Report 1031F-8P
Ambulatory Care Setting
G8751
Asthma: Tobacco Use: Intervention - 4000F & 1032F 1033F
232 N/A N/A N/A N/A 4000F-8P & 1032F
Ambulatory Care Setting 4001F & 1032F No Report
4001F-8P & 1032F
Thoracic Surgery: Recording of
233 0457 Performance Status Prior to Lung or 3328F N/A N/A N/A No Report 3328F-8P
Esophageal Cancer Resection
Thoracic Surgery: Pulmonary Function
Tests Before Major Anatomic Lung
234 0458 Resection (Pneumonectomy, 3038F 3038F-1P N/A N/A No Report 3038F-8P
Lobectomy, or Formal
Segmentectomy)
G8752 & G8755
G9231 G8753 & G8754
236 0018 Controlling High Blood Pressure G8752 & G8754 N/A N/A N/A
No Report G8753 & G8755
G8756
Ischemic Vascular Disease (IVD):
G8594
241 0075 Complete Lipid Profile and LDL-C G8593 & G8595 N/A N/A N/A No Report
G8593 & G8597
Control (<100mg/dl)
Individual Reporting via Registry:
1011F & 0557F
242 N/A Coronary Artery Disease (CAD): 1011F & 0557F-1P 1011F & 0557F-2P 1011F & 0557F-3P No Report 1011F & 0557F-8P
1012F
Symptom Management

Version 5.0 12/13/13 Page 14 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Measures Group Reporting:
1010F & 1011F & 0557F 1010F & 1011F & 0557F-8P
242 N/A Coronary Artery Disease (CAD): 1010F & 1011F & 0557F-1P 1011F & 0557F-2P 1011F & 0557F-3P No Report
1010F & 1012F 1010F-8P
Symptom Management
Cardiac Rehabilitation Patient Referral 4510F
243 0643 4500F 4500F-1P 4500F-2P 4500F-3P 4500F-8P
from an Outpatient Setting No Report
Chronic Wound Care: Use of Wound
Surface Culture Technique in Patients
245 AQA 4261F 4260F-1P N/A N/A No Report 4260F
with Chronic Skin Ulcers (Overuse
Measure)
Chronic Wound Care: Use of Wet to
246 AQA Dry Dressings in Patients with Chronic 4266F 4265F-1P N/A N/A No Report 4265F
Skin Ulcers (Overuse Measure)
Substance Use Disorders: Counseling
Regarding Psychosocial and
247 AQA 4320F N/A N/A N/A No Report 4320F-8P
Pharmacologic Treatment Options for
Alcohol Dependence
Substance Use Disorders: Screening
248 AQA for Depression Among Patients with 1220F 1220F-1P N/A N/A No Report 1220F-8P
Substance Abuse or Dependence
G8797
249 N/A Barrett's Esophagus 3125F 3125F-1P N/A N/A 3125F-8P
No Report
Radical Prostatectomy Pathology G8798
250 N/A 3267F 3267F-1P N/A N/A 3267F-8P
Reporting No Report
Immunohistochemical (IHC) Evaluation
of Human Epidermal Growth Factor 3395F
251 N/A 3394F N/A N/A N/A 3394F-8P
Receptor 2 Testing (HER2) for Breast No Report
Cancer Patients
Ultrasound Determination of
G8807
254 0651 Pregnancy Location for Pregnant G8806 N/A N/A N/A G8808
No Report
Patients with Abdominal Pain
Rh Immunoglobulin (Rhogam) for Rh-
G8810
255 0652 Negative Pregnant Women at Risk of G8809 N/A N/A N/A G8811
No Report
Fetal Blood Exposure
Statin Therapy at Discharge after G8815
257 N/A G8816 N/A N/A N/A G8817
Lower Extremity Bypass (LEB) No Report

Version 5.0 12/13/13 Page 15 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Rate of Open Repair of Small or
Moderate Non-Ruptured Abdominal
258 N/A Aortic Aneurysms (AAA) without Major G8818 N/A N/A N/A No Report G8825
Complications (Discharged to Home
by Post-Operative Day #7)
Rate of Endovascular Aneurysm
Repair (EVAR) of Small or Moderate
Non-Ruptured Abdominal Aortic G8826
259 N/A N/A N/A N/A No Report G8833
Aneurysms (AAA) without Major
Complications (Discharged to Home
by Post-Operative Day #2)
Rate of Carotid Endarterectomy (CEA)
for Asymptomatic Patients, without
260 N/A G8834 N/A N/A N/A No Report G8838
Major Complications (Discharged to
Home Post-Operative Day #2)
Referral for Otologic Evaluation for
G8857
261 N/A Patients with Acute or Chronic G8856 N/A N/A N/A G8858
No Report
Dizziness
Image Confirmation of Successful
G8873
262 N/A Excision of Image–Localized Breast G8872 N/A N/A N/A G8874
No Report
Lesion
G8876
Preoperative Diagnosis of Breast
263 N/A G8875 N/A N/A N/A G8946 G8877
Cancer
No Report
Sentinel Lymph Node Biopsy for G8880
264 N/A G8878 N/A N/A N/A G8882
Invasive Breast Cancer No Report
G8884
265 0645 Biopsy Follow-Up G8883 N/A N/A N/A G8885
No Report
Epilepsy: Seizure Type(s) and Current
266 N/A 1200F 1200F-1P 1200F-2P N/A No Report 1200F-8P
Seizure Frequency(ies)
Epilepsy: Documentation of Etiology of
267 N/A 1205F N/A N/A N/A No Report 1205F-8P
Epilepsy or Epilepsy Syndrome
Epilepsy: Counseling for Women of
268 N/A 4340F 4340F-1P N/A N/A No Report 4340F-8P
Childbearing Potential with Epilepsy
Inflammatory Bowel Disease (IBD):
269 N/A Type, Anatomic Location and Activity G0920 N/A G0921 N/A No Report G0922
All Documented

Version 5.0 12/13/13 Page 16 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Inflammatory Bowel Disease (IBD):
3750F
270 N/A Preventive Care: Corticosteroid G8859 & 4142F G8859 & 4142F-1P G8859 & 4142F-2P N/A G8859 & 4142F-8P
No Report
Sparing Therapy
Inflammatory Bowel Disease (IBD):
Preventive Care: Corticosteroid G8862
271 N/A G8860 & G8861 N/A N/A N/A G8860 & G8863
Related Iatrogenic Injury – Bone Loss No Report
Assessment
Inflammatory Bowel Disease (IBD):
4035F 4035F-1P 4035F-2P 4035F-3P 4035F-8P
272 N/A Preventive Care: Influenza No Report
4037F 4037F-1P 4037F-2P 4037F-3P 4037F-8P
Immunization
Inflammatory Bowel Disease (IBD): G8865
273 N/A Preventive Care: Pneumococcal G8864 N/A N/A N/A G8866 G8867
Immunization No Report
Inflammatory Bowel Disease (IBD):
Testing for Latent Tuberculosis (TB) 3510F & G8868
274 N/A 3510F-1P & G8868 3510F-2P & G8868 N/A No Report 3510F-8P & G8868
Before Initiating Anti-TNF (Tumor 6150F
Necrosis Factor) Therapy
Inflammatory Bowel Disease (IBD):
3517F
Assessment of Hepatitis B Virus (HBV) G8871
275 N/A G8869 3517F-1P 3517F-2P N/A 3517F-8P
Status Before Initiating Anti-TNF No Report
G8870
(Tumor Necrosis Factor) Therapy
Sleep Apnea: Assessment of Sleep G8840
276 N/A G8839 N/A N/A N/A G8841
Symptoms No Report
Sleep Apnea: Severity Assessment at G8843
277 N/A G8842 N/A N/A N/A G8844
Initial Diagnosis No Report
G8848
Sleep Apnea: Positive Airway
278 N/A G8845 & G8846 N/A N/A N/A G8849 & G8846 G8850 & G8846
Pressure Therapy Prescribed
No Report
Sleep Apnea: Assessment of G8853
279 N/A Adherence to Positive Airway Pressure G8851 & G8852 N/A N/A N/A G8854 & G8852 G8855 & G8852
Therapy No Report
1490F
280 N/A Dementia: Staging of Dementia 1491F N/A N/A N/A No Report 1490F-8P
1493F
281 N/A Dementia: Cognitive Assessment 1494F 1494F-1P 1494F-2P N/A No Report 1494F-8P
Dementia: Functional Status
282 N/A 1175F 1175F-1P N/A N/A No Report 1175F-8P
Assessment
Dementia: Neuropsychiatric Symptom
283 N/A 1181F N/A N/A N/A No Report 1181F-8P
Assessment
Version 5.0 12/13/13 Page 17 of 23
CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Dementia: Management of G8947 & 4525F G8948 G8947 & 4525F-8P
284 N/A N/A N/A N/A
Neuropsychiatric Symptoms G8947 & 4526F No Report G8947 & 4526F-8P
Dementia: Screening for Depressive
285 N/A 3725F N/A N/A N/A No Report 3725F-8P
Symptoms
Dementia: Counseling Regarding 6101F 6101F-1P 6101F-8P
286 N/A N/A N/A No Report
Safety Concerns 6102F 6102F-1P 6102F-8P
Dementia: Counseling Regarding
287 N/A 6110F 6110F-1P N/A N/A No Report 6110F-8P
Risks of Driving
Dementia: Caregiver Education and
288 N/A 4322F 4322F-1P N/A N/A No Report 4322F-8P
Support
Parkinson’s Disease: Annual
289 N/A 1400F N/A N/A N/A No Report 1400F-8P
Parkinson’s Disease Diagnosis Review
Parkinson’s Disease: Psychiatric
290 N/A 3700F N/A N/A N/A No Report 3700F-8P
Disorders or Disturbances Assessment
Parkinson’s Disease: Cognitive
291 N/A Impairment or Dysfunction 3720F N/A N/A N/A No Report 3720F-8P
Assessment
Parkinson’s Disease: Querying about
292 N/A 4328F 4328F-1P N/A N/A No Report 4328F-8P
Sleep Disturbances
Parkinson’s Disease: Rehabilitative
293 N/A 4400F 4400F-1P N/A N/A No Report 4400F-8P
Therapy Options
Parkinson’s Disease: Parkinson’s
294 N/A Disease Medical and Surgical 4325F 4325F-1P N/A N/A No Report 4325F-8P
Treatment Options Reviewed
Hypertension: Appropriate Use of
295 N/A Aspirin or Other Anththrombotic G8895 G8896 N/A N/A No Report G8897
Therapy
296 N/A Hypertension: Complete Lipid Profile G8767 G8768 N/A N/A No Report G8769
G8770
297 N/A Hypertension: Urine Protein Test G8772 N/A N/A No Report G8773
G8771
Hypertension: Annual Serum
298 N/A G8774 G8775 N/A N/A No Report G8776
Creatinine Test
Hypertension: Diabetes Mellitus
299 N/A G8777 G8778 N/A N/A No Report G8779
Screening Test
G8888
300 N/A Hypertension: Blood Pressure Control G8886 G8887 N/A N/A No Report
G8889
Hypertension: Low Density Lipoprotein G8891 G8893
301 N/A G8890 N/A N/A No Report
(LDL-C) Control G8892 G8894

Version 5.0 12/13/13 Page 18 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Hypertension: Dietary and Physical
302 N/A Activity Modifications Appropriately G8780 G8781 G8949 N/A No Report G8782
Prescribed
Cataracts: Improvement in Patient’s
G0914
303 N/A Visual Function within 90 Days G0913 N/A N/A N/A G0915
No Report
Following Cataract Surgery
Cataracts: Patient Satisfaction within G0917
304 N/A G0916 N/A N/A N/A G0918
90 Days Following Cataract Surgery No Report
Preventive Care and Screening: G8784
G8783 G8785
317 N/A Screening for High Blood Pressure N/A N/A N/A G8951
G8950 G8952
and Follow-Up Documented No Report
Endoscopy/Polyp Surveillance:
Appropriate Follow-Up Interval for
320 0658 0528F 0528F-1P N/A N/A No Report 0528F-8P
Normal Colonoscopy in Average Risk
Patients
Cardiac Stress Imaging Not Meeting G8961
Appropriate Use Criteria: Preoperative (NOTE: A lower performance
322 0670 N/A N/A N/A No Report G8962
Evaluation in Low Risk Surgery rate is desirable for this
Patients measure)
Cardiac Stress Imaging Not Meeting G8963
Appropriate Use Criteria: Routine (NOTE: A lower performance
323 0671 N/A N/A N/A No Report G8964
Testing After Percutaneous Coronary rate is desirable for this
Intervention (PCI) measure)
G8965
Cardiac Stress Imaging Not Meeting
(NOTE: A lower performance
324 0672 Appropriate Use Criteria: Testing in N/A N/A N/A No Report G8966
rate is desirable for this
Asyptomatic, Low-Risk Patients
measure)
Adult Major Depressive Disorder
325 N/A (MDD): Coordination of Care of G8959 N/A G9232 N/A No Report G8960
Patients with Comorbid Conditions
Atrial Fibrillation and Atrial Flutter: G8970
326 1525 G8967 & G8972 G8968 & G8972 G8969 & G8972 N/A G8971 & G8972
Chronic Anticoagulation Therapy No Report
Pediatric Kidney Disease: Adequacy of G8957
327 N/A G8955 & G8956 N/A N/A N/A G8958 & G8956
Volume Management No Report
G8973
Pediatric Kidney Disease: ESRD
(NOTE: A lower performance G8974
328 1667 Patients Receiving Dialysis: G8975 N/A N/A G8976
rate is desirable for this No Report
Hemoglobin Level < 10 g/dL
measure)

Version 5.0 12/13/13 Page 19 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
G9240
Adult Kidney Disease: Catheter Use at (NOTE: A lower performance G9239
329 N/A N/A N/A N/A G9241
Initiation of Hemodialysis rate is desirable for this No Report
measure)
G9265
Adult Kidney Disease: Catheter Use (NOTE: A lower performance G9264
330 N/A N/A N/A N/A G9266
for Greater Than or Equal to 90 Days rate is desirable for this No Report
measure)
G9286
Adult Sinusitis: Antibiotic Prescribed (NOTE: A lower performance
331 N/A N/A N/A N/A No Report G9287
for Acute Sinusitis (Appropriate Use) rate is desirable for this
measure)
Adult Sinusitis: Appropriate Choice of
G9313
332 N/A Antibiotic: Amoxicillin Prescribed for G9315 N/A N/A N/A G9314
No Report
Patients with Acute Bacterial Sinusitis
Adult Sinusitis: Computerized
G9348
333 N/A Tomography (CT) for Acute Sinusitis G9349 N/A N/A N/A G9350
No Report
(Overuse)
Adult Sinusitis: More than One G9352
Computerized Tomography (CT) Scan (NOTE: A lower performance G9353
334 N/A N/A N/A N/A G9354
Within 90 Days for Chronic Sinusitis rate is desirable for this No Report
(Overuse) measure)
Maternity Care: Elective Delivery or
335 N/A Early Induction Without Medical G9355 G9361 N/A N/A No Report G9356
Indication at ≥ 37 and < 39 Weeks
Maternity Care: Post-Partum Follow-
336 N/A G9357 N/A N/A N/A No Report G9358
Up and Care Coordination
Tuberculosis Prevention for Psoriasis
337 N/A and Psoriatic Arthritis Patients on a G9359 N/A N/A N/A No Report G9360
Biological Immune Response Modifier
338 2082 HIV Viral Load Suppression G9243 N/A N/A N/A No Report G9242
Prescription of HIV Antiretroviral
339 2083 G9245 N/A N/A N/A No Report G9244
Therapy
340 2079 HIV Medical Visit Frequency G9247 N/A N/A N/A No Report G9246
G9248
(NOTE: A lower performance
341 2080 Gap in HIV Medical Visits N/A N/A N/A No Report G9249
rate is desirable for this
measure)

Version 5.0 12/13/13 Page 20 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Pain Brought Under Control Within 48
342 0209 G9250 N/A N/A N/A No Report G9251
Hours
Screening Colonoscopy Adenoma
343 N/A G9252 N/A N/A N/A No Report G9253
Detection Rate
Rate of Carotid Artery Stenting (CAS)
for Asymptomatic Patients, Without
344 N/A G9255 N/A N/A N/A No Report G9254
Major Complications (Discharged to
Home by Post-Operative Day #2)
G9257
Rate of Postoperative Stroke or Death G9256
345 N/A in Asymptomatic Patients Undergoing (NOTE: A lower performance N/A N/A N/A No Report G9259
Carotid Artery Stenting (CAS) rate is desirable for this
measure)
G9258
Rate of Postoperative Stroke or Death G9260
346 N/A in Asymptomatic Patients Undergoing (NOTE: A lower performance N/A N/A N/A No Report G9261
Carotid Endarterectomy (CEA) rate is desirable for this
measure)
Rate of Endovascular Aneurysm
G9262
Repair (EVAR) of Small or Moderate
(NOTE: A lower performance
347 N/A Non-Ruptured Abdominal Aortic N/A N/A N/A No Report G9263
rate is desirable for this
Aneurysms (AAA) Who Die While in
measure)
Hospital
G9267
------------
N/A N/A N/A No Report G9269
HRS-3 Implantable Cardioverter- G9268
348 N/A ------------ ------------ ------------ ------------ ------------
Defibrillator (ICD) Complications Rate (NOTE: A lower performance
N/A N/A N/A No Report G9270
rate is desirable for this
measure)
G9272
G9271 & G9273 & G9275 & G9274
349 0076 Optimal Vascular Care Composite N/A N/A N/A No Report
G9277 G9276
G9278
Total Knee Replacement: Shared
350 N/A Decision-Making: Trial of Conservative G9296 N/A N/A N/A No Report G9297
(Non-surgical) Therapy
Total Knee Replacement: Venous
351 N/A Thromboembolic and Cardiovascular G9298 N/A N/A N/A No Report G9299
Risk Evaluation

Version 5.0 12/13/13 Page 21 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Total Knee Replacement:
352 N/A Preoperative Antibiotic Infusion G9301 G9300 N/A N/A No Report G9302
with Proximal Tourniquet
Total Knee Replacement: Identification
353 N/A of Implanted Prosthesis in Operative G9304 N/A N/A N/A No Report G9303
Report
G9306
(NOTE: A lower performance
354 N/A Anastomotic Leak Intervention N/A N/A N/A No Report G9305
rate is desirable for this
measure)
G9308
Unplanned Reoperation within the 30 (NOTE: A lower performance
355 N/A N/A N/A N/A No Report G9307
Day Postoperative Period rate is desirable for this
measure)
G9310
Unplanned Hospital Readmission (NOTE: A lower performance
356 N/A N/A N/A N/A No Report G9309
within 30 Days of Principal Procedure rate is desirable for this
measure)
G9312
(NOTE: A lower performance
357 N/A Surgical Site Infection (SSI) N/A N/A N/A No Report G9311
rate is desirable for this
measure)
Patient-centered Surgical Risk
358 N/A G9316 N/A N/A N/A No Report G9317
Assessment and Communication
Optimizing Patient Exposure to
Ionizing Radiation: Utilization of a
359 N/A Standardized Nomenclature for G9318 G9320 N/A N/A No Report G9319
Computed Tomography (CT)
Imaging Description
Optimizing Patient Exposure to
Ionizing Radiation: Count of
Potential High Dose Radiation
360 N/A G9321 G9323 N/A N/A No Report G9322
Imaging Studies: Computed
Tomography (CT) and Cardiac
Nuclear Medicine Studies
Optimizing Patient Exposure to
G9326
361 N/A Ionizing Radiation: Reporting to a G9327 G9325 N/A N/A No Report
G9324
Radiation Dose Index Registry
Version 5.0 12/13/13 Page 22 of 23
CPT only copyright 2013 American Medical Association. All rights reserved.
 PQRS NQF Medical Performance Patient Performance System Performance Other Performance Performance
Measure Title Meets Performance
Number Number Exclusion Exclusion Exclusion Exclusion Not Met
Optimizing Patient Exposure to
Ionizing Radiation: Computed
362 N/A Tomography (CT) Images G9340 G9328 N/A N/A No Report G9329
Available for Patient Follow-up and
Comparison Purposes
Optimizing Patient Exposure to
Ionizing Radiation: Search for Prior
Computed Tomography (CT)
363 N/A G9341 G9343 N/A G9344 No Report G9342
Studies Through a Secure,
Authorized, Media-Free, Shared
Archive
Optimizing Patient Exposure to
Ionizing Radiation:
Appropriateness: Follow-up CT
364 N/A G9345 G9346 N/A N/A No Report G9347
Imaging for Incidentally Detected
Pulmonary Nodules According to
Recommended Guidelines

Version 5.0 12/13/13 Page 23 of 23

CPT only copyright 2013 American Medical Association. All rights reserved.